Prednisone Terminated Phase 2 Trials for Stage IV Prostate Cancer / Adenocarcinoma of the Prostate Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00527124Docetaxel and Prednisone With or Without Cediranib in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy